285 studies found for:    Amyotrophic Lateral Sclerosis
Show Display Options
Rank Status Study
21 Active, not recruiting A Long-Term Study in Patients With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis (ALS)
Intervention: Drug: E0302 (mecobalamin)
22 Completed Memantine for Disability in Amyotrophic Lateral Sclerosis (MEDALS)
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: Memantine (Ebixa);   Drug: riluzole;   Drug: Placebo
23 Active, not recruiting Immunosuppression in Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis (ALS)
Interventions: Drug: Basiliximab;   Drug: Methylprednisolone;   Drug: Prednisone;   Drug: Tacrolimus;   Drug: Mycophenolate mofetil
24 Completed
Has Results
Insulin-like Growth Factor-1 in Amyotrophic Lateral Sclerosis (ALS) Trial
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: Insulin like growth factor, type 1;   Drug: Placebo
25 Completed Clinical Trial on the Use of Autologous Bone Marrow Stem Cells in Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Interventions: Procedure: Laminectomy and bone marrow stem cells transplantation;   Procedure: Autologous bone marrow cells collection
26 Terminated A Study of the Expression of Nogo and Reticulon Genes in Skeletal Muscle of Patients With Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Intervention:
27 Recruiting Toxin Treatment for Amyotrophic Lateral Sclerosis (ALS) Related Sialorrhea
Conditions: Sialorrhea;   Amyotrophic Lateral Sclerosis
Interventions: Drug: Botox injection;   Drug: Placebo injection
28 Terminated The Effect of Intensive Controlled Exercise in the Early Stages of Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Intervention: Behavioral: Intensive Controlled Exercise
29 Unknown  Study of Creatine Monohydrate in Patients With Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis (ALS)
Intervention: Drug: Creatine Monohydrate
30 Active, not recruiting Phase 3 Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis (ALS)
Interventions: Drug: MCI-186;   Drug: Placebo;   Drug: MCI-186 in open label phase
31 Temporarily not available Compassionate Treatment : An Exploratory Clinical Trial to Assess Treatment of Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Intervention: Procedure: Autologous Adipose-Tissue Derived Stem Cells
32 Active, not recruiting A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Intervention: Drug: Repository corticotropin injection
33 Completed Effects of Nocturnal Non-invasive Ventilation in Patients With Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Intervention: Device: non-invasive ventilation
34 Unknown  Safety Study of HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell Treatment in Amyotrophic Lateral Sclerosis
Conditions: Amyotrophic Lateral Sclerosis;   Motor Neuron Disease;   Neuromuscular Disease;   Neurodegenerative Disease;   Central Nervous System Disease
Intervention: Genetic: HYNR-CS-Allo
35 Active, not recruiting Study of Rasagiline in Patients With Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: Rasagiline;   Drug: Placebo
36 Terminated Noninvasive Examination of the Work of Breathing in Patients With Amyotrophic Lateral Sclerosis (ALS).
Conditions: Amyotrophic Lateral Sclerosis;   Neurodegenerative Disease;   Motor Neuron Disease
Intervention:
37 Completed G-CSF Treatment for Amyotrophic Lateral Sclerosis: A RCT Study Assessing Clinical Response
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: Granulocyte Colony Stimulating Factor;   Drug: NS
38 Unknown  Cistanche Total Glycosides for Amyotrophic Lateral Sclerosis: A Randomized Control Trial (RCT) Study Assessing Clinical Response
Condition: Amyotrophic Lateral Sclerosis
Intervention: Drug: Cistanche Total Glycosides
39 Completed
Has Results
Efficacy and Tolerability of Tauroursodeoxycholic Acid in Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: tauroursodeoxycholic acid (TUDCA);   Drug: Placebo
40 Active, not recruiting Autologous Cultured Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in Patients With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Intervention: Biological: MSC_NTF cells transplantation by multiple intramuscular injections at 24 separate sites, in addition to a single intrathechal injection into the CSF

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years